Ambitious but realistic! The EU unveils first steps toward Europe’s Beating Cancer Plan

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

Stakeholder Joint Statement: Prevention at the heart of Europe’s Beating Cancer Plan

From European Public Health Association

Prevention is the foundation of public health policy and central to protecting and improving people’s health and well-being. Europe’s Beating Cancer Plan is a key opportunity to put prevention where it belongs – at the heart of the European Union’s (EU) health agenda.

Opening remarks by Commissioner Kyriakides at the launch of the MEP Interest Group on antimicrobial resistance

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

Agenda: EMA Committee for Advanced Therapies (CAT) (19 – 21 February 2020)

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

Written Answer to a Question: Spinal muscular atrophy (SMA) — Zolgensma — Novartis

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

In-Depth Analysis: Addressing health inequalities in the European Union: Concepts, action, state of play

Tackling socially determined inequalities in health, both between and within European Union (EU) Member States, is still a major challenge. This analysis describes the main concepts and gives examples for health inequalities across the EU. It then presents an overview of the work accomplished at international and EU levels. It shows, in particular, how the EU institutions, bodies and agencies have contributed to reducing health inequalities, notwithstanding that Member States have the main responsibility for health policy. The analysis then goes on to depict stakeholder views, before closing with an outlook on avenues for further action.

Press Release: Capacity building of the European Reference Networks to develop and adapt clinical decision-making tools addressing rare diseases: the ERN-Clinical Guidelines Programme

In a meeting held in Brussels last 6th February, the Commission introduced a new project to provide technical assistance to the ERNs for the development, appraisal and implementation of Clinical Practice Guidelines (CPGs) and Clinical Decision Support Tools (CDSTs). This 4 years contract will enable the ERNs to adopt a common methodology and develop their own decision-making tools: 48 new CPGs are expected and 120 existing CPGs will be adapted to the specific rare diseases they are addressing.

OPP Meeting Summary: EP ENVI Committee – Exchange of Views with Commissioner Kyriakides (18 February 2020)

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

Speech by Commissioner Kyriakides: Bigger than Life – Rare Disease Day 2020

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

Agenda: EMA Committee for Orphan Medicinal Products (COMP) (18 – 20 February 2020)

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

Event: Opening reception: Phil L. Herold’s exhibition inside the European Parliament (Brussels, 18 February 2020)

In light of Rare Diseases Day 2020, EU40 is a delight to co-organise Phil L. Herold’s exhibition inside the European Parliament, an exhibition of artwork and life.

The opening reception of the exhibition will take place on February 18th at the European Parliament, 5G Space.

This event will be hosted by MEP  Stelios Kympouropoulos, MEP Tomislav Sokol, and MEP Loucas Fourlas. We will count on the presence and welcome words of Commissioner for Health and Food Safety, Stella Kyriakides to open this inclusive initiative and have the chance to witness a performance by soprano Noémie Desquiotz Sunnen, living with ALS.

Applications for new human medicines under evaluation by the Committee for Medicinal Products for Human Use

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

Minutes: EMA Paediatric Committee (PDCO) Meeting (23 – 26 July 2019)

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

UPDATED – EMA Paediatric Committee (PDCO)(17-20 September 2019)

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

Event: EP ENVI Committee Workshop on Cancer prevention – Modifiable risk factors (Brussels, 18 February 2020)

Europe’s Beating Cancer Plan is expected by the end of the year, and preparatory work and consultations are currently ongoing to shape the plan, set priorities and outline future action. This workshop looks into one of the key topics, modifiable risk factors and cancer prevention. Experts from all across the cancer spectrum will discuss with MEPs the state of play and main challenges, with a special angle on paediatric, digestive and HPV cancers.

UPDATED – Comitology Written Consultation: Standing Committee on medicinal products for human use

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

European Commission launches EU-wide public consultation on Europe’s Beating Cancer Plan

Today, on World Cancer Day, the European Commission is launching an EU-wide public consultation on Europe’s Beating Cancer Plan. The consultation will help shape the Plan, identify key areas, and explore future action.

UPDATED – Agenda: EMA Committee for medicinal products for human use (CHMP) (27 – 30 January 2020)

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

At a Glance: Europe’s Beating Cancer plan: Launch of an EU-wide debate

On 4 February 2020, on the occasion of World Cancer Day, the European Commission will initiate a broad stakeholder debate on the proposed Europe’s Beating Cancer plan, to be rolled out towards the end of the year. The launch event will be held in the European Parliament in Brussels, supported by the MEPs Against Cancer Interest Group. It will bring together political leaders, representatives from international organisations, health ministries, leading academics, scientists and health professionals, the private sector and non-governmental organisations, and cancer patients and survivors.

Our brain has a barrier that stops drugs. How do we get past it?

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

Agenda: EMA Paediatric Committee (PDCO) (28-31 January 2020)

Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen.  If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. Cookies help you create your Policy Newsfeed for example. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close